Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Juniper Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Juniper Pharma Acquires Three New Products to its Proprietary Pipeline 12
Partnerships 13
Juniper Pharma Services Enters into Agreement with Crystec Pharma 13
Molecular Profiles Enters Into Co-Development Agreement With Telormedix 14
Molecular Profiles Enters Into Agreement With Onyx Scientific 15
Licensing Agreements 16
Dare Bioscience Enters into Licensing Agreement with Juniper Pharma 16
Juniper Pharma Enters into Licensing Agreement with Harvard Medical, Massachusetts General Hospital and Massachusetts Institute of Technology 18
Columbia Labs Enters into Licensing Agreement for IVR Technology 20
Asset Transactions 21
Lil’ Drug Store Exercises Option to Acquire Rights for Legatrin PM from Columbia Labs for USD2.2 Million 21
Acquisition 22
Catalent Acquires Juniper Pharma 22
Columbia Labs Acquires Molecular Profiles For US$25 Million 24
Juniper Pharmaceuticals Inc – Key Competitors 25
Juniper Pharmaceuticals Inc – Key Employees 26
Juniper Pharmaceuticals Inc – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Strategy And Business Planning 28
Sep 18, 2017: Juniper Pharmaceuticals Announces Strategic Reprioritization 28
Financial Announcements 30
Aug 09, 2018: Juniper Pharmaceuticals reports second quarter 2018 financial and operating results 30
May 10, 2018: Juniper Pharmaceuticals Reports First Quarter 2018 Financial and Operating Results 31
Mar 08, 2018: Juniper Pharmaceuticals Reports Full-Year 2017 Financial and Operating Results 32
Nov 02, 2017: Juniper Pharmaceuticals Reports Third Quarter 2017 Financial and Operating Results 34
Aug 03, 2017: Juniper Pharmaceuticals Reports Second Quarter 2017 Financial and Operating Results 35
May 04, 2017: Juniper Pharmaceuticals Reports First Quarter 2017 Financial and Operating Results 36
Mar 07, 2017: Juniper Pharmaceuticals Reports Fourth Quarter and Full-Year 2016 Financial and Operating Results 38
Corporate Communications 40
Mar 21, 2018: Juniper Pharmaceuticals Appoints Richard Messina to Board of Directors 40
Sep 11, 2017: Juniper Pharmaceuticals Appoints Jennifer Good to Board of Directors 41
Other Significant Developments 42
Jan 31, 2018: Juniper Pharmaceuticals to Explore Strategic Alternatives 42
Jan 02, 2018: Juniper Pharma Outlines Strategic Priorities for 2018 and Reports Recent Portfolio Progress 43
Aug 08, 2017: Major Progress in Next Generation Medicines Initiative 44
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Juniper Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Juniper Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Juniper Pharma Acquires Three New Products to its Proprietary Pipeline 12
Juniper Pharma Services Enters into Agreement with Crystec Pharma 13
Molecular Profiles Enters Into Co-Development Agreement With Telormedix 14
Molecular Profiles Enters Into Agreement With Onyx Scientific 15
Dare Bioscience Enters into Licensing Agreement with Juniper Pharma 16
Juniper Pharma Enters into Licensing Agreement with Harvard Medical, Massachusetts General Hospital and Massachusetts Institute of Technology 18
Columbia Labs Enters into Licensing Agreement for IVR Technology 20
Lil’ Drug Store Exercises Option to Acquire Rights for Legatrin PM from Columbia Labs for USD2.2 Million 21
Catalent Acquires Juniper Pharma 22
Columbia Labs Acquires Molecular Profiles For US$25 Million 24
Juniper Pharmaceuticals Inc, Key Competitors 25
Juniper Pharmaceuticals Inc, Key Employees 26
Juniper Pharmaceuticals Inc, Subsidiaries 27
List of Figures
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Juniper Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10